The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Elderly patients have limited access to systemic therapy for metastatic renal cell carcinoma (mRCC) and shorter overall survival in Russia, Belarus and Kazakhstan.
 
Ilya Tsimafeyeu
Leadership - Ruspharmtech
Stock and Other Ownership Interests - Ruspharmtech
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Ruspharmtech
Research Funding - Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Kidney Cancer Research Bureau; Oncomax LLC; Ruspharmtech
 
Sergei Krasny
No Relationships to Disclose
 
Nurzhan Nurgaliyev
No Relationships to Disclose
 
Ilya Varlamov
No Relationships to Disclose
 
Vladislav Petkau
No Relationships to Disclose
 
Sufia Safina
No Relationships to Disclose
 
Ruslan Zukov
No Relationships to Disclose
 
Mikhail Mazhbich
No Relationships to Disclose
 
Galina Statsenko
No Relationships to Disclose
 
Olga Novikova
No Relationships to Disclose
 
Igor Zaitsev
No Relationships to Disclose
 
Dilara Kaidarova
No Relationships to Disclose
 
Oxana Shatkovskaya
No Relationships to Disclose
 
Pavel Moiseyev
No Relationships to Disclose
 
Alexander Rolevich
No Relationships to Disclose
 
Alesya Evmenenko
No Relationships to Disclose
 
Irina L. Popova
No Relationships to Disclose
 
Liubov Yu Vladimirova
No Relationships to Disclose